- Home
- OLMA vs IBEX Comparison
OLMA vs IBEX Comparison
Compare OLMA & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- IBEX
- Stock Information
- Founded
- OLMA 2006
- IBEX 2017
- Country
- OLMA United States
- IBEX United States
- Employees
- OLMA N/A
- IBEX N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- IBEX EDP Services
- Sector
- OLMA Health Care
- IBEX Technology
- Exchange
- OLMA Nasdaq
- IBEX Nasdaq
- Market Cap
- OLMA 289.0M
- IBEX 307.4M
- IPO Year
- OLMA 2020
- IBEX 2020
- Fundamental
- Price
- OLMA $4.42
- IBEX $23.35
- Analyst Decision
- OLMA Strong Buy
- IBEX Buy
- Analyst Count
- OLMA 3
- IBEX 2
- Target Price
- OLMA $27.67
- IBEX $25.00
- AVG Volume (30 Days)
- OLMA 1.2M
- IBEX 153.0K
- Earning Date
- OLMA 05-07-2025
- IBEX 05-08-2025
- Dividend Yield
- OLMA N/A
- IBEX N/A
- EPS Growth
- OLMA N/A
- IBEX 37.48
- EPS
- OLMA N/A
- IBEX 2.13
- Revenue
- OLMA N/A
- IBEX $521,725,000.00
- Revenue This Year
- OLMA N/A
- IBEX $6.47
- Revenue Next Year
- OLMA N/A
- IBEX $4.29
- P/E Ratio
- OLMA N/A
- IBEX $10.95
- Revenue Growth
- OLMA N/A
- IBEX 1.66
- 52 Week Low
- OLMA $2.86
- IBEX $13.00
- 52 Week High
- OLMA $16.62
- IBEX $27.83
- Technical
- Relative Strength Index (RSI)
- OLMA 60.78
- IBEX 42.30
- Support Level
- OLMA $2.96
- IBEX $23.22
- Resistance Level
- OLMA $3.41
- IBEX $24.29
- Average True Range (ATR)
- OLMA 0.35
- IBEX 1.13
- MACD
- OLMA 0.16
- IBEX -0.06
- Stochastic Oscillator
- OLMA 98.73
- IBEX 48.58
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.